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Summary
Objectives: To study the epidemiology of snake bite patients evaluated at the Royal
Hospital, Muscat, Sultanate of Oman, and to study their clinical course and outcome.
Methods: A retrospective study of 65 adult patients presenting at Royal Hospital
following a snake bite from May 2006 to August 2008.
Results: The main symptoms were local pain at the bite site (26 patients, 40%) and
swelling (17 patients, 26%). Only ﬁve patients (7.7%) had signs of bleeding. After
assessment, only 47 of the 65 patients were admitted. White cell count (WCC) was
raised in 15 cases (23%) on presentation to the emergency room. Prothrombin time
was prolonged in 34 patients (52%) and APTT was prolonged in 25 patients (38%) on
presentation. Thirty-six patients received anti-snake venom (antivenom) at a mean
time of 8 h after the bite and 4 h after arrival in the emergency department. Patients
with deranged coagulation proﬁle needed a mean of fourteen vials of antivenom for
correction of the abnormal coagulation proﬁle. Two patients died: both had delayed
presentation to the hospital.
Conclusion: Patients with envenoming following snakebite should receive antivenom
as soon as possible: delayed presentation or administration may be very dangerous.
The decision to give antivenom should be initiated as soon as possible after patients’
arrival at the Emergency Department and the use of the whole blood clotting test
(WBCT) may facilitate the early administration of antivenom.
© 2009 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
.Ltd. All rights reserved∗ Corresponding author at: P.O. Box 2657, CPO 111, Muscat,
man. Tel.: +968 24599000; fax: +968 24599966.
E-mail address: salabri@gmail.com (S.S. Al-Abri).
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Table 1 Patient gender, site of bites and time of bite.
No of patients (n = 65)
Sex
Males 59
Females 6
Site of bite
Upper limbs 25
Lower limbs 39
Neck 1
Time of day
Morning 15
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at the bite site was most common. None had symp-
toms or signs of neurotoxicity. Bleeding occurred in
only 7.7% of patients. Swelling of the limb occurred
in 26% of the patients. Blistering or skin necrosis168
deaths occur each year worldwide due to snake
bite [1]. A study done in Saudi Arabia showed
that 2.4% of the total admissions to a regional
hospital (from May 2002 to May 2005) were due
to snake bites [2]. The incidence of snakebite is
not known in Oman: there have been no formal
studies, snakebite is a non-reportable condition
and it is treated in multiple centres. Early medical
attention and administration of antivenom, when
indicated, are the main outcome determinants [3].
However, in many parts of the world, there are
continuing crises in the production, deployment,
and accessibility of antivenom [4].
Most Omani snakes are harmless. Of the 9 ven-
omous terrestrial snakes, 9% of envenomations are
by the Saw-scaled Viper (Echis carinatus). This
aggressive snake occurs throughout Oman, espe-
cially in rocky areas. About 9% of bites are caused
by a related species, Burton’s carpet snake (Echis
coloratus) of hilly regions, or the Horned Viper
(Cerastes gasperetti) of deserts. All three vipers
have broad heads and 2-hinged fangs, and the
venom causes impaired clotting. Only in Dhofar are
found the non-aggressive Arabian cobra (venom is
neurotoxic) and the indolent Puff adder (impaired
clotting), but bites have never been reported in this
region [5].
Methods
The records of all patients with snake bite evalu-
ated in Royal Hospital from May 2006 to August 2008
were reviewed. Since January 2006 the Royal Hos-
pital became a paperless hospital, all the medical
records of patients were computerized includ-
ing investigations, medications and case notes of
patients. The inclusion criteria were age over 13
(considered as an adult patient in Royal Hospital)
and conﬁrmed or strongly suspected snake bite.
Patients with an uncertain history of snake bite or
other animal and insect stings were excluded.
Clinical information (age, gender and co-morbid
conditions), snake bite-related information (such
as time, place and snake type) and management-
related information (such as laboratory tests,
treatment given to the patient and the ﬁnal
outcome of the case) were extracted from the
patients’ records. The treatment sheet was missing
in 3 cases.Results
A total of 85 patients were evaluated at the Royal
Hospital from the period of May 2006 to August
F
sEvening 39
Not available 11
008. Fifteen of them were children and so they
ere not included in the study. Four patients with
corpion or bee stings were incorrectly labelled as
aving snake bite. A single patient presented with
welling and he was thought to have snake bite
ut that case was excluded because of lack of any
upportive clinical examination or investigations.
ata were therefore available for 65 patients.
ighteen patients were discharged from the Emer-
ency Department after envenoming was excluded
nd 47 patients were admitted to the medical
ards.
Most of the patients were males in the 21—30
ear age group. Male-to-female ratio was 9:1. Most
f the bites happened in the afternoon or evening
nd most of the bites were on the lower limbs (see
able 1). Most patients (40 cases) were bitten by
nakes in the desert. Snakes were rarely adequately
escribed. The mean time between the bite and
rrival to emergency room was 5 h.
Presenting symptoms are shown in Fig. 1. Painigure 1 Symptoms of patients who presented with
nake bites.
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as not seen. Only one patient presented in shock
blood pressure of 80/60mmHg). He was success-
ully resuscitated with intravenous ﬂuids.
At presentation, 34 (52%) of the patients had
n abnormal coagulation proﬁle. Prothrombin time
as more commonly deranged upon presentation
han the activated partial thromboplastin time
APTT). Two patients developed delayed deranged
oagulation, 6 h after admission to the medical
ards. Fifteen patients presented with leucocyto-
is (WCC> 11× 109). Eight patients had an abnormal
reatinine at presentation: only one of them was
nown to have previous renal impairment crea-
inine levels recovered to baseline in all eight
atients by discharge. CK was not recorded in most
f the cases. Only one patient developed severe
enal impairment requiring renal replacement ther-
py due to snake bite envenoming.
36 (55%) patients received anti-snake venom
antivenom) (Saudi Guard polyvalent anti-snake
enom). The mean time from arrival at the
mergency room to ﬁrst dose of antivenom was
pproximately 4 h in these 36 patients, it ranged
etween 35min and 895min; the mean was
33.65min and standard deviation of 167.8. Nine
atients received further antivenom despite the
act that the coagulation proﬁle had normalised.
he average number of vials needed to normalise
oagulation was 14 vials; the range was from 1
ial to 55 vials, with mean of 13.56 vials and stan-
ard deviation of 12.65. However, some patients
eceived as many as 61 vials to normalise their
oagulation proﬁle. Thirty-four patients (52%) were
re-medicated with anti-histamines and 29 (45%)
eceived steroids. Thirty-two patients received
ntibiotics although there was no evidence of
ecrosis or infection at the site of the bite.
ifty-eight patients were discharged home with
o long-term complications. Three patients left
gainst medical advice and a patient absconded
rom the hospital. Two patients died with intrac-
rebral bleeding and disseminated intravascular
oagulopathy respectively. Both patients were pre-
ented a few days after the snake bite. They lived
n rural areas and they used traditional treat-
ent instead of seeking medical advice. They were
nconscious on admission to the hospital. One
atient developed acute renal failure because of
he snake bite. He was normotensive upon admis-
ion with a creatinine of 165mol/l. Following
dmission, his renal function progressively deteri-
rated and he was started on haemodialysis when
is creatinine exceeded 400mol/l and he devel-
ped oliguria. His renal function improved after
aemodialysis and he was discharged home with
ormal renal function.
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iscussion
he proﬁle of patients and bites in Omanwas similar
o many other studies conducted in Asia and Africa
6,7]; most patients were males aged 21—30 years
nd most events took place in the evening the usual
rrigation time in Oman. This also explains why most
f the patient could not give a good description of
he offending snake.
In the absence of good descriptions and because
his was a retrospective study, we were unable to
dentify the biting species. The main species of ven-
mous snake in the north of Oman are E. carinatus
ochureki and E. omanensis. Both of these are likely
o cause shock, incoagulable blood and bleeding.
Despite the absence of deﬁnitive identiﬁcation,
here are still some useful lessons to be learnt from
his study. Although most of the patients reached
he hospital within 2—3h of the bite, some took
uch longer, either because they had no means of
ransport or because they delayed seeking medi-
al help as they lived in rural areas and they did
ot take the bite seriously. Early presentation to
he emergency room is closely linked to increased
fﬁcacy of the antivenom and good outcomes [3].
ducation of the population about the potential
dverse consequences of snakebite and delayed
resentation in areas where it is common could be
ery important.
Thirty-two patients received antibiotics
lthough there was no documentation of local
nﬂammation or signs of infection signs. Some
ppear to have been started on antibiotics because
f leucocytosis, some prophylactically and some
ecause they had some swelling at the bite site.
ntibiotics are normally necessary in snakebite
f there is necrosis of the wound and there is
enerally no role for routine antibiotic prophylaxis
8]. Education of medical personnel is necessary to
revent unnecessary prescription of antibiotics.
Over half of the patients were pre-medicated
ith antihistamine and/or steroids prior to receiv-
ng antivenom. Despite this, 2 patients had
‘anaphylactoid’’ shock after starting antivenom.
hey were treated with epinephrine, antihistamine
nd steroids and both fully recovered. The role of
outine prophylaxis is still highly debated and only
drenaline has ever been shown to be of beneﬁt in
linical trials [9].
The average time from presentation to the emer-
ency room to receive ﬁrst dose of antivenom was
pproximately 4 h. This delay could be potentially
ife-threatening. It sometimes occurred because of
ack of antivenom at the Emergency Department
nd sometimes because antivenom was started only
fter the patient reached to the ward. In addi-
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tion, laboratory results of coagulation proﬁle took
around 90—120min to be released. Evidence of a
coagulopathy was the major indication for com-
mencing antivenom. This can be achieved by simply
using the whole blood clotting test (WBCT), a bed-
side test which if used in our practice, could shorten
the time between arrival at the Emergency Depart-
ment and starting antivenom to less than 30min [3].
The average number of vials needed to restore
coagulation was 13. Nine out of the 36 patients
who received antivenom received further doses
of antivenom after restoring coagulation. The aim
of these doses was to ensure the persistence
of the normal coagulation, although there is no
rationale for this with most antivenoms. This prac-
tice reﬂects the differences in the amount and
frequency of administration of antivenom rec-
ommended by guidelines produced by different
countries and organizations [3,10,11] and guide-
lines for Oman and the middle east would be useful.
Appropriate training may also help to improve out-
comes as demonstrated in other settings [12].
Only 2 patients died. One of them presented
3 days after the snakebite in a coma. His ini-
tial head CT showed evidence of an intracerebral
bleed. He was referred for neurosurgical interven-
tion but it was not successful. The other patient
had severe coagulopathy and bleeding from the
gums that did not respond to antivenom: he died
suddenly with a presumed intracerebral bleed. A
single patient had acute renal failure that improved
dramatically and was discharged with follow up
in the nephrology clinic to ensure normal renal
function. The overall mortality rate was 3.1%. The
ﬁnding that eight patients appeared to have mild
renal impairment is also interesting as this is not
a feature of Echis sp. bites and although it may
reﬂect pre-existing renal disease, warrants further
study.
Conclusion
This study shows the lack of proper reporting
of snake bite cases and the potential for snake
bite to be catastrophic if patients do not present
rapidly or management is delayed. The manage-
ment of snakebite could be improved by use of the
20min WBCT and rapid administration of antivenom
in appropriate doses. In general, only moderate
amounts of antivenom were needed to restore
[
Available online at www.A. Al-Lawati et al.
oagulation in most patients. The variation in clini-
al practice reﬂects lack of deﬁnitive guidance and
ocal Omani guidelines incorporating some of these
oints would help to improve the management of
nakebite.
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